PRA Health Sciences has launched Symphony Health’s new national market measurement tool, Metys, an integrated, all-in-one market research solution available from a contract research organization (CRO).
 
Metys is designed to provide pharmaceutical market analytics and intelligence that is timely and comprehensive, to help life sciences to manage diverse portfolios with imporved accuracy, reliability and agility.
 
Powered by IDV, the company’s Integrated Dataverse, Metys integrates prescriber, payer, and patient data assets. Source of business, managed care and other key metrics are also included to provide a complete picture of market activity. Metys has customizable dashboards and reporting. According to the company, Metys is the only national market measurement solution in the industry that includes linked Diagnosis subgroups to projected prescriptions and writers.
 
“Because understanding, measuring and influencing treatment decisions is increasingly complex, PRA and Symphony Health have developed a solution that quickly and efficiently brings all of the data to clients’ fingertips within the Metys^TM platform,” said Doug Fulling, President of Symphony Health. “This offering affirms our commitment to serving our clients at the highest level with tools that will move their business forward, while also reinforcing our culture of innovation and excellence.”